BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36928336)

  • 1. Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation.
    Huang X; Li G; Li L; Wang J; Shen J; Chen Y; Yu W; Chen A; Wu T; Ma J; Ling B; He L; Chen X
    Sci Rep; 2023 Mar; 13(1):4403. PubMed ID: 36928336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.
    Hu W; Yuan L; Zhang X; Ni Y; Hong D; Wang Z; Li X; Ling Y; Zhang C; Deng W; Tian M; Ding R; Song C; Li J; Zhang X
    Cancer Sci; 2022 May; 113(5):1843-1854. PubMed ID: 35238118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
    Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
    Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience.
    Pei J; Zhao X; Patchefsky AS; Flieder DB; Talarchek JN; Testa JR; Wei S
    Medicine (Baltimore); 2019 Jun; 98(25):e16031. PubMed ID: 31232935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
    Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
    Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
    Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
    Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.
    Antonescu CR; Dickson BC; Zhang L; Sung YS; Fletcher CD
    Mod Pathol; 2021 Aug; 34(8):1541-1546. PubMed ID: 33859361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implications of a Targeted RNA-Sequencing Panel in the Detection of Gene Fusions in Solid Tumors.
    Sun L; McNulty SN; Evenson MJ; Zhu X; Robinson JA; Mann PR; Duncavage EJ; Pfeifer JD
    J Mol Diagn; 2021 Dec; 23(12):1749-1760. PubMed ID: 34562614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
    Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
    Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma Showcase.
    Decock A; Creytens D; Lefever S; Van der Meulen J; Anckaert J; De Ganck A; Deleu J; De Wilde B; Fierro C; Kuersten S; Luypaert M; Rottiers I; Schroth GP; Steyaert S; Vanderheyden K; Vanden Eynde E; Verniers K; Verreth J; Van Dorpe J; Vandesompele J
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
    Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
    Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.
    Peters TL; Kumar V; Polikepahad S; Lin FY; Sarabia SF; Liang Y; Wang WL; Lazar AJ; Doddapaneni H; Chao H; Muzny DM; Wheeler DA; Okcu MF; Plon SE; Hicks MJ; López-Terrada D; Parsons DW; Roy A
    Mod Pathol; 2015 Apr; 28(4):575-86. PubMed ID: 25360585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New fusion sarcomas: histopathology and clinical significance of selected entities.
    Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J
    Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving sarcoma classification by using RNA hybridisation capture sequencing in sarcomas of uncertain histogenesis of young individuals.
    Vargas AC; Heyer EE; Cheah AL; Bonar F; Jones M; Maclean FM; Gill AJ; Blackburn J
    Pathology; 2023 Jun; 55(4):478-485. PubMed ID: 36906400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ChildSeq-RNA: A next-generation sequencing-based diagnostic assay to identify known fusion transcripts in childhood sarcomas.
    Qadir MA; Zhan SH; Kwok B; Bruestle J; Drees B; Popescu OE; Sorensen PH
    J Mol Diagn; 2014 May; 16(3):361-70. PubMed ID: 24517889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts.
    Hofvander J; Tayebwa J; Nilsson J; Magnusson L; Brosjö O; Larsson O; von Steyern FV; Domanski HA; Mandahl N; Mertens F
    Lab Invest; 2015 Jun; 95(6):603-9. PubMed ID: 25867764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ analysis of soft tissue tumor associated genetic alterations in formalin-fixed paraffin-embedded tissue.
    Horn H; Allmanritter J; Doglioni C; Marx A; Müller J; Gattenlöhner S; Staiger AM; Rosenwald A; Ott G; Ott MM
    Pathol Res Pract; 2014 Dec; 210(12):804-11. PubMed ID: 25446247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of sarcoma-specific fusion gene analysis in paraffin-embedded material for routine diagnosis at a specialist centre.
    Thway K; Rockcliffe S; Gonzalez D; Swansbury J; Min T; Thompson L; Fisher C
    J Clin Pathol; 2010 Jun; 63(6):508-12. PubMed ID: 20439326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of an RNA Sequencing Assay for Gene Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tumors.
    Peng H; Huang R; Wang K; Wang C; Li B; Guo Y; Li M; Zhang D; Dong H; Chen H; Chen C; Xu Q; Li F; Tian L; Wu J
    J Mol Diagn; 2021 Feb; 23(2):223-233. PubMed ID: 33271368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.